Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2249848 Title: UTILISATION DE CANNABINOÏDES EN COMBINAISON AVEC DE l'ARIPIPRAZOLE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
088695341
WO application number:
GB2008004217
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2249848
WO publication number:
WO2009087351
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
17/12/2008
Grant date:
18/05/2016
EP publication date:
17/11/2010
WO publication date:
16/07/2009
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
18/05/2016
EP B1 publication date:
18/05/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
17/12/2028

Applicant

1

Name:
GW Pharma Limited
Legal Form:
From:
18/05/2016
Address:
Sovereign House, Histon Cambridge CB24 9BZ, United Kingdom (GB)
To:

2

Name:
Otsuka Pharmaceutical Co., Limited
Legal Form:
From:
18/05/2016
Address:
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535, Japan (JP)
To:

Inventor

1

Name:
KIKUCHI, Tetsuro
Legal Form:
Address:
Osaka 541-0045, Japan (JP)

2

Name:
MAEDA, Kenji
Legal Form:
Address:
Osaka 541-0045, Japan (JP)

3

Name:
GUY, Geoffrey
Legal Form:
Address:
Salisbury, Wiltshire SP4 0JR, United Kingdom (GB)

4

Name:
ROBSON, Philip
Legal Form:
Address:
Salisbury, Wiltshire SP4 0JQ, United Kingdom (GB)

5

Name:
STOTT, Colin
Legal Form:
Address:
Salisbury, Wiltshire SP4 0JQ, United Kingdom (GB)

Priority

Priority patent number:
0800390
Priority date:
04/01/2008
Priority country:
United Kingdom (GB)

Classification

IPC or IDT classification:
A61K 36/185; A61K 31/352; A61K 31/35; A61K 31/05; A61K 45/06; A61P 25/18; A61P 25/22;

Publication

European Patent Bulletin

1

Issue number:
201620
Publication date:
18/05/2016
Description:
Grant (B1)

2

Issue number:
201623
Publication date:
08/06/2016
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
02/01/2017
Annual fee number:
9
Annual fee amount:
165 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type